Virginie Cogez

Virginie Cogez

Auto-generated profile, based on publicly available information

Virginie Cogez

Univ. Lille CNRS UMR 8576 UGSF Unité de Glycobiologie Structurale et Fonctionnelle 59000 Lille France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2017 in ChemBioChem
Verified
Journal Article
Open access
PDF file
MNMaxence Noel
Maxence Noel
PGPierre-André Gilormini
Pierre-André Gilormini
VCVirginie Cogez
Virginie Cogez
NYNao Yamakawa
Nao Yamakawa
DVDorothée Vicogne
Dorothée Vicogne
AHAnne Harduin-Lepers
Anne Harduin-Lepers
Sialylation of glycoproteins and glycolipids is catalyzed by sialyltransferases in the Golgi of mammalian cells, whereby sialic acid residues are added at the nonreducing ends of oligosaccharides. Because sialylated glycans play critical roles in a number of human physio‐pathological processes, the past two decades have witnessed the development of modified sialic acid derivatives for a better understanding of sialic acid biology and for the development of new therapeutic targets. However, nothing is known about how individual mammalian sialyltransferases tolerate and behave towards these unnatural CMP‐sialic acid donors. In this study, we devised several approaches to investigate the donor specificity of the human β‐d‐galactoside sialyltransferases ST6Gal I and ST3Gal I by using two CMP‐sialic acids: CMP‐Neu5Ac, and CMP‐Neu5N‐(4pentynoyl)neuraminic acid (CMP‐SiaNAl), an unnatural CMP‐sialic acid donor with an extended and functionalized N‐acyl moiety.

22 October 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SBSébastien BONTEMPS-GALLO
Sébastien BONTEMPS-GALLO
VCVirginie Cogez
Virginie Cogez
CMCatherine Robbe Masselot
Catherine Robbe Masselot
KQKevin Quintard
Kevin Quintard
JDJacqueline Dondeyne
Jacqueline Dondeyne
JLJean-Marie Lacroix
Jean-Marie Lacroix
Osmoregulated periplasmic glucans (OPGs) are oligosaccharides found in the periplasm of many Gram-negative bacteria. Glucose is the sole constitutive sugar and this backbone may be substituted by various kinds of molecules depending on the species. InE. coli, OPG are substituted by phosphoglycerol and phosphoethanolamine derived from membrane phospholipids and by succinyl residues. In this study, we describe the isolation of theopgEgene encoding the phosphoethanolamine transferase by a screen previously used for the isolation of theopgBgene encoding the phosphoglycerol transferase. Both genes show structural and functional similarities without sequence similarity.

16 August 2021 in ChemBioChem
Verified
Journal Article
Open access
PDF file
SGSophie Groux-Degroote
Sophie Groux-Degroote
DVDorothée Vicogne
Dorothée Vicogne
VCVirginie Cogez
Virginie Cogez
CSCeline Schulz
Celine Schulz
AHAnne Harduin-Lepers
Anne Harduin-Lepers
The Sda carbohydrate antigen and the corresponding biosynthetic enzyme B4GALNT2 are primarily expressed in human normal colonic mucosa and are down‐regulated to variable degrees in colon cancer. On the other hand, the tumor associated antigen SLex is not detected in the healthy colon and is upregulated in colon cancer. High level of B4GALNT2 gene expression appears to be a good marker of prognosis in colon cancer; however, the molecular mechanisms regulating these carbohydrate antigens’ expression are still poorly understood. We review here the most recent progress made towards understanding this balanced expression of blood group carbohydrate epitopes Sda and SLex. In particular in recent years, we have attained a better understanding of genetic and epigenetic regulation of the B4GALNT2 gene and of the subcellular fate of B4GALNT2 isoforms.